Meyenburg–Altherr–Uehlinger syndrome
Meyenburg–Altherr–Uehlinger syndrome is a rare genetic disorder characterized by microcephaly, intellectual disability, and growth retardation. It was first described by the Swiss physicians Meyenburg, Altherr, and Uehlinger in 1968.
Symptoms and Signs[edit | edit source]
The most common symptoms of Meyenburg–Altherr–Uehlinger syndrome include microcephaly, which is a condition where the head is significantly smaller than normal due to a problem with brain development. Other symptoms include intellectual disability, which affects learning and cognitive abilities, and growth retardation, which results in a slower than normal growth rate.
Causes[edit | edit source]
Meyenburg–Altherr–Uehlinger syndrome is a genetic disorder, which means it is caused by abnormalities in the genes. However, the exact genetic cause of this syndrome is currently unknown. It is thought to be inherited in an autosomal recessive manner, which means both parents must carry a copy of the mutated gene for a child to be affected.
Diagnosis[edit | edit source]
Diagnosis of Meyenburg–Altherr–Uehlinger syndrome is based on the presence of the characteristic symptoms and signs. Genetic testing may also be used to confirm the diagnosis and identify the specific genetic mutation.
Treatment[edit | edit source]
There is currently no cure for Meyenburg–Altherr–Uehlinger syndrome. Treatment is supportive and focuses on managing the symptoms. This may include physical therapy, special education, and other supportive services.
Prognosis[edit | edit source]
The prognosis for individuals with Meyenburg–Altherr–Uehlinger syndrome varies depending on the severity of the symptoms. Some individuals may have a normal lifespan, while others may have a reduced lifespan due to complications associated with the syndrome.
See also[edit | edit source]
NIH genetic and rare disease info[edit source]
Meyenburg–Altherr–Uehlinger syndrome is a rare disease.
| Meyenburg–Altherr–Uehlinger syndrome Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
